from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3129/-

LFCtreatmentdescriptionclass of inhibitor

0.861

Amikacinug/mL Amikacintranslation

0.403

Cap5-10ug/mL Capreomycintranslation

-0.017

Rox10-50 ug/mL Roxithromycintranslation

-0.173

SM2-5 ug/mL Streptomycintranslation

0.917

Tet5-10 ug/mL Tetracyclinetranslation

0.706

Rif0.2-5ug/mL Rifampicintranscription

-0.296

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.412

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.953

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.227

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.537

Clofazimine10-13 ug/mL Clofaziminerespiration

0.986

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.752

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.485

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.118

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.256

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.593

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.095

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.274

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.092

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.001

KCN5-20 ug/mL Potassium cyaniderespiration

0.240

NaN30.2-2 mM Sodium aziderespiration

-0.506

Nigericin50 uM Nigericinrespiration

-0.348

TRC10-150 ug/mL Triclosanrespiration

0.662

TRZ10-25 ug/mL Thioridazinerespiration

0.280

Valinomycin0.5-10 uM Valinomycinrespiration

-0.267

ZnSO42 mM ZnSO4respiration

0.390

menadione6-10 ug/mL Menadionerespiration

-0.234

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.222

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.283

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.046

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.006

NRP_1Non-replicating persistence stage 1dosRassociated

-0.447

Amp0.2mg/mL AmpicillincellWall

0.815

Cephalexin20-100 ug/mL CephalexincellWall

0.574

Cerulenin0.32-5 ug/mL CerulenincellWall

0.945

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.544

EMB10-20 ug/mL EthambutolcellWall

0.098

Eta12-40 ug/mL EthionamidecellWall

0.248

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.322

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.760

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.061

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.973

BZA0.12 mg/mL BenzamidearomaticAmides

-0.493

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.004

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.071

H2O24 mM hydrogen peroxideDNAdamaging

-0.163

Levo10 ug/mL LevofloxacinDNAdamaging

-0.467

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.341

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.170

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.807

UVUV-irradiationDNAdamaging

0.108

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.304

Antimycin12.5-50 ug/mL Antimycin A?

-0.668

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.272

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.606

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.910

PA8240.2-2 ug/mL PA-824?

1.360

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.526

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.360

Verapamil50 uM Verapamil?

-0.264

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.683

methoxatin10-20 ug/mL Methoxatin?